US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

31.80

-0.6800-2.09%

Post-market: 31.800.00000.00%19:30 EDT

Volume:569.93K

Turnover:18.22M

Market Cap:1.89B

PE:-4.54

High:32.82

Open:32.82

Low:31.65

Close:32.48

52wk High:46.00

52wk Low:22.24

Shares:59.47M

Float Shares:50.09M

Volume Ratio:0.47

T/O Rate:1.14%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-7.0075

EPS(LYR):-7.1203

ROE:-34.34%

ROA:-22.24%

PB:1.84

PE(LYR):-4.47

Loading ...

Overview Company News Filings

Agios Pharmaceuticals price target lowered to $40 from $41 at BofA

BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune

BRIEF-Agios Provides Update On Phase 2B Trial Of Tebapivat In Lower-Risk Myelodysplastic Syndromes

BUZZ-U.S. STOCKS ON THE MOVE-Costco, Firefly Aerospace, Agios

Agios Pharma Won't Advance Tebapivat for Lower-Risk Myelodysplastic Syndromes

Agios Halts Development of Tebapivat in Lower-Risk MDS After Mid-Stage Trial Miss; Shares Drop Premarket

MT Newswires Live

Agios will not advance tebapivat in lower-risk myelodysplastic syndromes

Agios Pharmaceuticals Shares Fall 19% Premarket After Co to Stop Development of Its Blood Disorder Drug

THOMSON REUTERS

Agios scraps blood disorder drug program after study miss

Agios Pharmaceuticals - Tebapivat Phase 2 Trial in Sickle Cell Disease Topline Data Expected Second Half 2026

THOMSON REUTERS

Agios Pharmaceuticals - Phase 2B Trial Results for Tebapivat in Lr-Mds Did Not Meet Predefined Threshold

THOMSON REUTERS

Agios Pharmaceuticals - Tebapivat Well Tolerated With No New Safety Signals Identified

THOMSON REUTERS

Agios Pharmaceuticals - Will Not Advance Tebapivat in Lower-Risk Myelodysplastic Syndromes

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Clinuvel Pharmaceuticals (OtherCLVLF) and Agios Pharma (AGIO)

Will EU Thalassemia Approval for PYRUKYND Redefine Agios Pharmaceuticals' (AGIO) Mitapivat-Centric Investment Narrative?

Simply Wall St.

Analysts Are Bullish on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Agios Pharma (AGIO)

BRIEF-Avanzanite Bioscience’S Partner Agios Announces Pyrukynd® (Mitapivat) Approval In EU

Agios Gets EU Approval for Pyrukynd in Thalassemia

MT Newswires Live

Agios says EU approves PYRUKYND for adults with alpha- or beta-thalassemia anemia

Agios’ Pyrukynd® (Mitapivat) Approved in the European Union for Adults With Thalassemia

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/AGIO/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"AGIO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGIO\",,,,,undefined,":{"symbol":"AGIO","market":"US","secType":"STK","nameCN":"Agios Pharmaceuticals","latestPrice":31.8,"timestamp":1790971200000,"preClose":32.48,"halted":0,"volume":569934,"hourTrading":{"tag":"盘后","latestPrice":31.8,"preClose":31.8,"latestTime":"19:30 EDT","volume":20676,"amount":657496.5,"timestamp":1790983804695,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02093596059113289,"floatShares":50088500,"shares":59471609,"eps":-7.007511,"marketStatus":"Market Closed","change":-0.68,"latestTime":"10-02 16:00:00 EDT","open":32.82,"high":32.82,"low":31.65,"amount":18219910.001904,"amplitude":0.036022,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.007511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791187200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1374638400000,"exchange":"NASDAQ","adjPreClose":32.48,"preHourTrading":{"tag":"盘前","latestPrice":32.81,"preClose":32.48,"latestTime":"09:29 EDT","volume":2394,"amount":77856.471,"timestamp":1790947799999,"change":0.33,"changeRate":0.01016,"amplitude":0.020012},"postHourTrading":{"tag":"盘后","latestPrice":31.8,"preClose":31.8,"latestTime":"19:30 EDT","volume":20676,"amount":657496.5,"timestamp":1790983804695,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.47393323151982986,"impliedVol":0.868,"impliedVolPercentile":0.8884},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AGIO\",,,,,undefined,":{"symbol":"AGIO","floatShares":50088500,"roa":"-22.24%","roe":"-34.34%","lyrEps":-7.12035,"volumeRatio":0.47393323151982986,"shares":59471609,"dividePrice":0,"high":32.82,"amplitude":0.036022,"preClose":32.48,"low":31.65,"week52Low":22.24,"pbRate":"1.84","psRate":"19.23","week52High":46,"institutionHeld":0,"latestPrice":31.8,"eps":-7.007511,"divideRate":0,"volume":569934,"delay":0,"ttmEps":-7.007511,"open":32.82,"prevYearClose":27.22,"prevWeekClose":32.58,"prevMonthClose":33.25,"prevQuarterClose":33.25,"fiveDayClose":32.58,"twentyDayClose":33.13,"sixtyDayClose":42.79},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AGIO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-30","symbol":"AGIO","fiscalQuarterEnding":"2026/06","expectedEps":-1.86,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785384000000,"reportTimeType":"pre","actualEps":-1.69},{"market":"US","date":"2026-04-29","symbol":"AGIO","fiscalQuarterEnding":"2026/03","expectedEps":-1.81,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777435200000,"reportTimeType":"pre","actualEps":-1.69},{"market":"US","date":"2026-02-12","symbol":"AGIO","fiscalQuarterEnding":"2025/12","expectedEps":-1.97,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1770872400000,"reportTimeType":"pre","actualEps":-1.74},{"market":"US","date":"2025-10-30","symbol":"AGIO","fiscalQuarterEnding":"2025/09","expectedEps":-1.93,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761796800000,"reportTimeType":"pre","actualEps":-1.78},{"market":"US","date":"2025-07-31","symbol":"AGIO","fiscalQuarterEnding":"2025/06","expectedEps":-1.74,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":-1.93}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AGIO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"AGIO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.4,"hold":0.3,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4,"analysts":10,"updateTime":1764129600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/AGIO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"AGIO","date":"2026-10-02","current":-4.537988,"percent":0.392333,"low":-7.861811,"twenty":-5.888865,"median":-4.167558,"eighty":2.139193,"high":5.213257,"avg":-2.720639,"sd":3.749477,"marketCap":1939117127},"quantilePoints":[{"date":"2021-10-08","current":1.63615,"twenty":-17.006866,"median":-10.196658,"eighty":-7.169517,"marketCap":2603886385},{"date":"2021-10-15","current":1.714309,"twenty":-16.833879,"median":-10.086102,"eighty":-7.121555,"marketCap":2728273985},{"date":"2021-10-22","current":1.798394,"twenty":-16.748215,"median":-10.019911,"eighty":-7.029954,"marketCap":2862093819},{"date":"2021-10-29","current":1.740979,"twenty":-16.661093,"median":-9.901023,"eighty":-6.976936,"marketCap":2770719043},{"date":"2021-11-05","current":1.549215,"twenty":-16.560338,"median":-9.739095,"eighty":-6.852957,"marketCap":2481354177},{"date":"2021-11-12","current":1.424437,"twenty":-16.521362,"median":-9.698706,"eighty":-6.665724,"marketCap":2281498992},{"date":"2021-11-19","current":1.295929,"twenty":-16.426169,"median":-9.666045,"eighty":-6.61614,"marketCap":2075669876},{"date":"2021-11-26","current":1.235913,"twenty":-16.384124,"median":-9.632348,"eighty":-6.577798,"marketCap":1979543877},{"date":"2021-12-03","current":1.160301,"twenty":-16.299755,"median":-9.561047,"eighty":-6.489558,"marketCap":1858435980},{"date":"2021-12-10","current":1.002972,"twenty":-16.17901,"median":-9.52559,"eighty":-6.452996,"marketCap":1606444660},{"date":"2021-12-17","current":1.151824,"twenty":-16.119888,"median":-9.493214,"eighty":-6.384574,"marketCap":1844858861},{"date":"2021-12-23","current":1.214891,"twenty":-15.950833,"median":-9.472456,"eighty":-6.332645,"marketCap":1945872623},{"date":"2021-12-31","current":1.114526,"twenty":-15.91134,"median":-9.417131,"eighty":-6.233744,"marketCap":1785119540},{"date":"2022-01-07","current":1.104354,"twenty":-15.863365,"median":-9.316182,"eighty":-6.170512,"marketCap":1768826998},{"date":"2022-01-14","current":1.123681,"twenty":-15.816189,"median":-9.274101,"eighty":-5.994075,"marketCap":1799782828},{"date":"2022-01-21","current":1.010431,"twenty":-15.770449,"median":-9.240886,"eighty":-5.905057,"marketCap":1618392525},{"date":"2022-01-28","current":1.019247,"twenty":-15.716221,"median":-9.223344,"eighty":-5.764439,"marketCap":1632512728},{"date":"2022-02-04","current":0.97449,"twenty":-15.633597,"median":-9.181883,"eighty":-5.693623,"marketCap":1560825542},{"date":"2022-02-11","current":1.062309,"twenty":-15.497637,"median":-9.151805,"eighty":-5.652668,"marketCap":1701484490},{"date":"2022-02-18","current":0.997547,"twenty":-15.455293,"median":-9.093891,"eighty":-5.501308,"marketCap":1597755305},{"date":"2022-02-25","current":1.048341,"twenty":-15.379348,"median":-9.066785,"eighty":-5.436185,"marketCap":1682288655},{"date":"2022-03-04","current":1.073537,"twenty":-15.347193,"median":-9.034367,"eighty":-5.366724,"marketCap":1722720406},{"date":"2022-03-11","current":0.977181,"twenty":-15.324057,"median":-8.988048,"eighty":-5.230331,"marketCap":1568096278},{"date":"2022-03-18","current":1.004079,"twenty":-15.267146,"median":-8.954245,"eighty":-5.128337,"marketCap":1611259904},{"date":"2022-03-25","current":0.980245,"twenty":-15.21105,"median":-8.884745,"eighty":-5.065271,"marketCap":1573013653},{"date":"2022-04-01","current":1.025529,"twenty":-15.114059,"median":-8.87277,"eighty":-4.961222,"marketCap":1645681530},{"date":"2022-04-08","current":1.003057,"twenty":-15.068459,"median":-8.842142,"eighty":-4.936927,"marketCap":1609620779},{"date":"2022-04-14","current":0.949942,"twenty":-14.954121,"median":-8.835685,"eighty":-4.886933,"marketCap":1524386277},{"date":"2022-04-22","current":0.826347,"twenty":-14.890342,"median":-8.79943,"eighty":-4.785242,"marketCap":1326052149},{"date":"2022-04-29","current":0.75011,"twenty":-14.797015,"median":-8.753566,"eighty":0.775232,"marketCap":1203712726},{"date":"2022-05-06","current":-3.401152,"twenty":-14.749097,"median":-8.732453,"eighty":0.793881,"marketCap":1239325528},{"date":"2022-05-13","current":-3.325972,"twenty":-14.650243,"median":-8.684168,"eighty":0.793881,"marketCap":1211931065},{"date":"2022-05-20","current":-3.172605,"twenty":-14.591838,"median":-8.666929,"eighty":0.793881,"marketCap":1156046359},{"date":"2022-05-27","current":-2.981647,"twenty":-14.506956,"median":-8.657687,"eighty":0.793881,"marketCap":1086464422},{"date":"2022-06-03","current":-2.959093,"twenty":-14.45752,"median":-8.644613,"eighty":0.793881,"marketCap":1078246083},{"date":"2022-06-10","current":-2.781668,"twenty":-14.392097,"median":-8.586723,"eighty":0.793881,"marketCap":1013595149},{"date":"2022-06-17","current":-2.701977,"twenty":-14.341471,"median":-8.559247,"eighty":0.793881,"marketCap":984557018},{"date":"2022-06-24","current":-3.393634,"twenty":-14.222936,"median":-8.53999,"eighty":0.79668,"marketCap":1236586082},{"date":"2022-07-01","current":-3.512419,"twenty":-14.161322,"median":-8.488601,"eighty":0.79668,"marketCap":1279869334},{"date":"2022-07-08","current":-3.909371,"twenty":-14.09167,"median":-8.469852,"eighty":0.79668,"marketCap":1424512102},{"date":"2022-07-15","current":-3.354541,"twenty":-14.043078,"median":-8.456475,"eighty":0.79668,"marketCap":1222340961},{"date":"2022-07-22","current":-3.080885,"twenty":-13.918885,"median":-8.418695,"eighty":0.79668,"marketCap":1122625114},{"date":"2022-07-29","current":-3.243274,"twenty":-13.775938,"median":-8.396203,"eighty":0.79668,"marketCap":1181797155},{"date":"2022-08-05","current":-4.406507,"twenty":-13.645543,"median":-8.374359,"eighty":0.79668,"marketCap":1630288777},{"date":"2022-08-12","current":-4.170921,"twenty":-13.567028,"median":-8.356243,"eighty":0.79668,"marketCap":1543128079},{"date":"2022-08-19","current":-3.785685,"twenty":-13.497792,"median":-8.310728,"eighty":0.79668,"marketCap":1400601151},{"date":"2022-08-26","current":-3.970894,"twenty":-13.378592,"median":-8.282277,"eighty":0.79668,"marketCap":1469123713},{"date":"2022-09-02","current":-4.719141,"twenty":-13.231912,"median":-8.268635,"eighty":0.79668,"marketCap":1745954860},{"date":"2022-09-09","current":-5.058445,"twenty":-13.113426,"median":-8.248172,"eighty":0.79668,"marketCap":1871488192},{"date":"2022-09-16","current":-4.569492,"twenty":-12.817567,"median":-8.227852,"eighty":0.79668,"marketCap":1690588631},{"date":"2022-09-23","current":-4.295382,"twenty":-12.418301,"median":-8.209583,"eighty":0.79668,"marketCap":1589175240},{"date":"2022-09-30","current":-4.190183,"twenty":-12.119184,"median":-8.178258,"eighty":0.79668,"marketCap":1550254425},{"date":"2022-10-07","current":-4.013863,"twenty":-11.92785,"median":-8.164702,"eighty":0.79668,"marketCap":1485020947},{"date":"2022-10-14","current":-3.996083,"twenty":-11.829039,"median":-8.130071,"eighty":0.79668,"marketCap":1478442781},{"date":"2022-10-21","current":-4.000528,"twenty":-11.75369,"median":-8.103228,"eighty":0.79668,"marketCap":1480087323},{"date":"2022-10-28","current":-4.246486,"twenty":-11.718712,"median":-8.084838,"eighty":0.79668,"marketCap":1571085284},{"date":"2022-11-04","current":-3.920805,"twenty":-11.652923,"median":-8.064005,"eighty":0.79668,"marketCap":1423071770},{"date":"2022-11-11","current":-4.430964,"twenty":-11.568649,"median":-8.054015,"eighty":0.79668,"marketCap":1608235935},{"date":"2022-11-18","current":-4.270498,"twenty":-11.422429,"median":-8.025664,"eighty":0.79668,"marketCap":1549994387},{"date":"2022-11-25","current":-4.39009,"twenty":-11.379876,"median":-7.990436,"eighty":0.79668,"marketCap":1593400824},{"date":"2022-12-02","current":-4.771574,"twenty":-11.30973,"median":-7.9634,"eighty":0.79668,"marketCap":1731861861},{"date":"2022-12-09","current":-4.262929,"twenty":-11.252863,"median":-7.918212,"eighty":0.79668,"marketCap":1547247144},{"date":"2022-12-16","current":-4.497572,"twenty":-11.231632,"median":-7.87747,"eighty":0.79668,"marketCap":1632411671},{"date":"2022-12-23","current":-4.091867,"twenty":-11.180852,"median":-7.845462,"eighty":0.79668,"marketCap":1485159457},{"date":"2022-12-30","current":-4.250818,"twenty":-11.131859,"median":-7.828687,"eighty":0.79668,"marketCap":1542851556},{"date":"2023-01-06","current":-4.437019,"twenty":-11.131859,"median":-7.806172,"eighty":0.79668,"marketCap":1610433729},{"date":"2023-01-13","current":-4.506655,"twenty":-11.107991,"median":-7.789266,"eighty":0.79668,"marketCap":1635708363},{"date":"2023-01-20","current":-4.262929,"twenty":-11.045253,"median":-7.777611,"eighty":0.79668,"marketCap":1547247144},{"date":"2023-01-27","current":-4.65501,"twenty":-10.974244,"median":-7.749133,"eighty":0.79668,"marketCap":1689554322},{"date":"2023-02-03","current":-4.571749,"twenty":-10.944374,"median":-7.685316,"eighty":0.79668,"marketCap":1659334651},{"date":"2023-02-10","current":-4.317427,"twenty":-10.887333,"median":-7.635055,"eighty":0.79668,"marketCap":1567027293},{"date":"2023-02-17","current":-4.190265,"twenty":-10.848977,"median":-7.618011,"eighty":0.79668,"marketCap":1520873614},{"date":"2023-02-24","current":-5.988809,"twenty":-10.805099,"median":-7.558995,"eighty":0.79668,"marketCap":1388211949},{"date":"2023-03-03","current":-5.829012,"twenty":-10.704899,"median":-7.492125,"eighty":0.79668,"marketCap":1351170850},{"date":"2023-03-10","current":-5.23991,"twenty":-10.662208,"median":-7.439663,"eighty":0.79668,"marketCap":1214616349},{"date":"2023-03-17","current":-5.547579,"twenty":-10.558304,"median":-7.395368,"eighty":0.79668,"marketCap":1285934286},{"date":"2023-03-24","current":-5.185054,"twenty":-10.503941,"median":-7.281447,"eighty":0.79668,"marketCap":1201900748},{"date":"2023-03-31","current":-5.478413,"twenty":-10.40816,"median":-7.23782,"eighty":0.793881,"marketCap":1269901572},{"date":"2023-04-06","current":-5.165974,"twenty":-10.326089,"median":-7.193005,"eighty":0.793881,"marketCap":1197477930},{"date":"2023-04-14","current":-5.368701,"twenty":-10.124796,"median":-7.156829,"eighty":0.79668,"marketCap":1244470369},{"date":"2023-04-21","current":-5.387782,"twenty":-10.056105,"median":-7.058155,"eighty":0.79668,"marketCap":1248893187},{"date":"2023-04-28","current":-5.351846,"twenty":-9.954469,"median":-7.007628,"eighty":0.79668,"marketCap":1240563255},{"date":"2023-05-05","current":-6.275765,"twenty":-9.781154,"median":-6.899662,"eighty":0.79668,"marketCap":1368399074},{"date":"2023-05-12","current":-6.469492,"twenty":-9.707883,"median":-6.805201,"eighty":0.79668,"marketCap":1410640475},{"date":"2023-05-19","current":-6.579102,"twenty":-9.686526,"median":-6.640358,"eighty":0.79668,"marketCap":1434540215},{"date":"2023-05-26","current":-6.571454,"twenty":-9.642254,"median":-6.633325,"eighty":0.79668,"marketCap":1432872791},{"date":"2023-06-02","current":-6.553611,"twenty":-9.584824,"median":-6.60479,"eighty":0.79668,"marketCap":1428982136},{"date":"2023-06-09","current":-6.780477,"twenty":-9.546549,"median":-6.60479,"eighty":0.79668,"marketCap":1478449040},{"date":"2023-06-16","current":-6.579102,"twenty":-9.516315,"median":-6.581651,"eighty":0.79668,"marketCap":1434540215},{"date":"2023-06-23","current":-6.864595,"twenty":-9.480916,"median":-6.580227,"eighty":0.79948,"marketCap":1496790701},{"date":"2023-06-30","current":-6.997146,"twenty":-9.435445,"median":-6.579102,"eighty":0.802279,"marketCap":1525692712},{"date":"2023-07-07","current":-6.890086,"twenty":-9.32363,"median":-6.579102,"eighty":0.802279,"marketCap":1502348780},{"date":"2023-07-14","current":-7.127148,"twenty":-9.289067,"median":-6.579102,"eighty":0.802279,"marketCap":1554038916},{"date":"2023-07-21","current":-6.836556,"twenty":-9.253531,"median":-6.579102,"eighty":0.802279,"marketCap":1490676814},{"date":"2023-07-28","current":-6.525572,"twenty":-9.230763,"median":-6.579102,"eighty":0.802279,"marketCap":1422868249},{"date":"2023-08-04","current":-6.883656,"twenty":-9.183439,"median":-6.579102,"eighty":0.802279,"marketCap":1445877597},{"date":"2023-08-11","current":-7.109219,"twenty":-9.169988,"median":-6.579102,"eighty":0.802279,"marketCap":1493256007},{"date":"2023-08-18","current":-6.891617,"twenty":-9.102601,"median":-6.579102,"eighty":0.802279,"marketCap":1447549776},{"date":"2023-08-25","current":-7.056146,"twenty":-9.068769,"median":-6.579102,"eighty":0.802279,"marketCap":1482108146},{"date":"2023-09-01","current":-7.279055,"twenty":-9.036262,"median":-6.579102,"eighty":0.802279,"marketCap":1528929163},{"date":"2023-09-08","current":-6.910193,"twenty":-8.999954,"median":-6.579102,"eighty":0.802279,"marketCap":1451451528},{"date":"2023-09-15","current":-7.133103,"twenty":-8.961084,"median":-6.579102,"eighty":0.802279,"marketCap":1498272545},{"date":"2023-09-22","current":-6.607673,"twenty":-8.92345,"median":-6.578274,"eighty":0.802279,"marketCap":1387908719},{"date":"2023-09-29","current":-6.573175,"twenty":-8.876501,"median":-6.571454,"eighty":0.802279,"marketCap":1380662609},{"date":"2023-10-06","current":-6.509487,"twenty":-8.850539,"median":-6.525572,"eighty":0.802279,"marketCap":1367285176},{"date":"2023-10-13","current":-6.095512,"twenty":-8.836187,"median":-6.509487,"eighty":0.802279,"marketCap":1280331858},{"date":"2023-10-20","current":-5.684191,"twenty":-8.804828,"median":-6.486238,"eighty":0.802279,"marketCap":1193935934},{"date":"2023-10-27","current":-5.511702,"twenty":-8.760544,"median":-6.475866,"eighty":0.812727,"marketCap":1157705385},{"date":"2023-11-03","current":-5.329728,"twenty":-8.736739,"median":-6.461727,"eighty":0.812727,"marketCap":1170525426},{"date":"2023-11-10","current":-5.435875,"twenty":-8.693252,"median":-6.446261,"eighty":0.812727,"marketCap":1193837826},{"date":"2023-11-17","current":-5.659825,"twenty":-8.670706,"median":-6.385684,"eighty":0.812727,"marketCap":1243022156},{"date":"2023-11-24","current":-5.682729,"twenty":-8.662217,"median":-6.364569,"eighty":0.812727,"marketCap":1248052371},{"date":"2023-12-01","current":-5.65728,"twenty":-8.650226,"median":-6.311031,"eighty":0.812727,"marketCap":1242463243},{"date":"2023-12-08","current":-5.888865,"twenty":-8.618025,"median":-6.246238,"eighty":0.808903,"marketCap":1293324311},{"date":"2023-12-15","current":-5.914314,"twenty":-8.563298,"median":-6.199891,"eighty":0.812727,"marketCap":1298913440},{"date":"2023-12-22","current":-5.820153,"twenty":-8.561591,"median":-6.167575,"eighty":0.820375,"marketCap":1278233665},{"date":"2023-12-29","current":-5.799794,"twenty":-8.561934,"median":-6.132664,"eighty":0.824199,"marketCap":1273762362},{"date":"2024-01-05","current":-5.972846,"twenty":-8.562616,"median":-6.088349,"eighty":0.824629,"marketCap":1311768435},{"date":"2024-01-12","current":-5.748896,"twenty":-8.541302,"median":-6.016938,"eighty":0.824629,"marketCap":1262584105},{"date":"2024-01-19","current":-5.425696,"twenty":-8.502338,"median":-5.980797,"eighty":0.825058,"marketCap":1191602174},{"date":"2024-01-26","current":-5.960122,"twenty":-8.479154,"median":-5.948027,"eighty":0.824629,"marketCap":1308973871},{"date":"2024-02-02","current":-5.843057,"twenty":-8.456789,"median":-5.915586,"eighty":0.824629,"marketCap":1283263880},{"date":"2024-02-09","current":-6.153533,"twenty":-8.420702,"median":-5.914314,"eighty":0.824629,"marketCap":1351451247},{"date":"2024-02-16","current":-6.820293,"twenty":-8.395098,"median":-5.914314,"eighty":0.824629,"marketCap":1497886411},{"date":"2024-02-23","current":-4.753024,"twenty":-8.374445,"median":-5.888865,"eighty":0.824629,"marketCap":1673482543},{"date":"2024-03-01","current":-5.158419,"twenty":-8.357929,"median":-5.853237,"eighty":0.824199,"marketCap":1816217455},{"date":"2024-03-08","current":-5.006795,"twenty":-8.325633,"median":-5.829681,"eighty":0.824199,"marketCap":1762832350},{"date":"2024-03-15","current":-4.70195,"twenty":-8.285687,"median":-5.809974,"eighty":0.824199,"marketCap":1655500192},{"date":"2024-03-22","current":-4.826442,"twenty":-8.270476,"median":-5.771771,"eighty":0.824199,"marketCap":1699332173},{"date":"2024-03-28","current":-4.647685,"twenty":-8.260445,"median":-5.755989,"eighty":0.824199,"marketCap":1636393944},{"date":"2024-04-05","current":-4.456159,"twenty":-8.228259,"median":-5.725903,"eighty":0.824629,"marketCap":1568960128},{"date":"2024-04-12","current":-4.888687,"twenty":-8.209583,"median":-5.711951,"eighty":0.824629,"marketCap":1721248163},{"date":"2024-04-19","current":-4.697162,"twenty":-8.179081,"median":-5.68346,"eighty":0.824629,"marketCap":1653814347},{"date":"2024-04-26","current":-5.054676,"twenty":-8.168027,"median":-5.667948,"eighty":0.824199,"marketCap":1779690804},{"date":"2024-05-03","current":-5.567508,"twenty":-8.130353,"median":-5.65728,"eighty":0.824199,"marketCap":1963209164},{"date":"2024-05-10","current":-5.300242,"twenty":-8.108439,"median":-5.61913,"eighty":0.824199,"marketCap":1868966040},{"date":"2024-05-17","current":-5.63513,"twenty":-8.10001,"median":-5.583479,"eighty":0.824199,"marketCap":1987053810},{"date":"2024-05-24","current":-5.263211,"twenty":-8.076409,"median":-5.561068,"eighty":0.824199,"marketCap":1855908258},{"date":"2024-05-31","current":-6.044079,"twenty":-8.066921,"median":-5.560453,"eighty":0.824199,"marketCap":2131257143},{"date":"2024-06-07","current":-7.695977,"twenty":-8.060809,"median":-5.560453,"eighty":0.824199,"marketCap":2713747774},{"date":"2024-06-14","current":-7.530143,"twenty":-8.036683,"median":-5.558143,"eighty":0.824629,"marketCap":2655271619},{"date":"2024-06-21","current":-6.834607,"twenty":-7.988696,"median":-5.555834,"eighty":0.825058,"marketCap":2410012406},{"date":"2024-06-28","current":-7.021372,"twenty":-7.944695,"median":-5.546155,"eighty":0.826347,"marketCap":2475869047},{"date":"2024-07-05","current":-6.765376,"twenty":-7.912892,"median":-5.546155,"eighty":0.826347,"marketCap":2385600031},{"date":"2024-07-12","current":-7.146955,"twenty":-7.912892,"median":-5.546155,"eighty":0.826347,"marketCap":2520151960},{"date":"2024-07-15","current":-7.38685,"twenty":-7.912892,"median":-5.546155,"eighty":0.826347,"marketCap":2604743680},{"date":"2024-08-02","current":-6.922944,"twenty":-7.868507,"median":-5.519111,"eighty":0.862166,"marketCap":2526396987},{"date":"2024-08-09","current":-6.826907,"twenty":-7.868507,"median":-5.519111,"eighty":0.862166,"marketCap":2491350162},{"date":"2024-08-16","current":-7.001517,"twenty":-7.868507,"median":-5.519111,"eighty":0.862166,"marketCap":2555070468},{"date":"2024-08-23","current":-7.124678,"twenty":-7.868507,"median":-5.519111,"eighty":0.862166,"marketCap":2600016041},{"date":"2024-08-30","current":-7.149623,"twenty":-7.868507,"median":-5.519111,"eighty":0.862166,"marketCap":2609118941},{"date":"2024-09-06","current":-6.865883,"twenty":-7.868507,"median":-5.524946,"eighty":0.862166,"marketCap":2505573445},{"date":"2024-09-13","current":-7.003076,"twenty":-7.868507,"median":-5.544732,"eighty":0.862166,"marketCap":2555639399},{"date":"2024-09-20","current":-7.386592,"twenty":-7.868507,"median":-5.560453,"eighty":0.862166,"marketCap":2695596499},{"date":"2024-09-27","current":-7.491046,"twenty":-7.868507,"median":-5.580934,"eighty":0.862166,"marketCap":2733714896},{"date":"2024-10-04","current":-6.323347,"twenty":-7.868507,"median":-5.619594,"eighty":0.862166,"marketCap":2307585352},{"date":"2024-10-11","current":-6.519782,"twenty":-7.868507,"median":-5.65728,"eighty":0.862166,"marketCap":2379270696},{"date":"2024-10-18","current":-6.881473,"twenty":-7.868507,"median":-5.673576,"eighty":0.862166,"marketCap":2511262758},{"date":"2024-10-25","current":-7.02802,"twenty":-7.868507,"median":-5.691597,"eighty":0.862166,"marketCap":2564742300},{"date":"2024-10-31","current":-7.218219,"twenty":-7.868507,"median":-5.724071,"eighty":0.862166,"marketCap":2634151919},{"date":"2024-11-08","current":4.65844,"twenty":-7.868915,"median":-5.725032,"eighty":0.932397,"marketCap":3141223140},{"date":"2024-11-15","current":4.685504,"twenty":-7.868915,"median":-5.720903,"eighty":0.971324,"marketCap":3159472803},{"date":"2024-11-22","current":4.697345,"twenty":-7.868915,"median":-5.678912,"eighty":0.979505,"marketCap":3167457030},{"date":"2024-11-29","current":5.022962,"twenty":-7.868915,"median":-5.664512,"eighty":0.991133,"marketCap":3387023281},{"date":"2024-12-06","current":4.98744,"twenty":-7.868915,"median":-5.642735,"eighty":0.999652,"marketCap":3363070599},{"date":"2024-12-13","current":3.228261,"twenty":-7.868915,"median":-5.597475,"eighty":1.008709,"marketCap":2176842543},{"date":"2024-12-20","current":3.028662,"twenty":-7.833469,"median":-5.563366,"eighty":1.016806,"marketCap":2042251282},{"date":"2024-12-27","current":2.906873,"twenty":-7.804542,"median":-5.546155,"eighty":1.023822,"marketCap":1960127802},{"date":"2025-01-03","current":2.692896,"twenty":-7.777025,"median":-5.524946,"eighty":1.037605,"marketCap":1815841408},{"date":"2025-01-10","current":3.036274,"twenty":-7.749133,"median":-5.511702,"eighty":1.048341,"marketCap":2047384000},{"date":"2025-01-17","current":2.691205,"twenty":-7.671364,"median":-5.478413,"eighty":1.053493,"marketCap":1814700804},{"date":"2025-01-24","current":2.992295,"twenty":-7.635055,"median":-5.454806,"eighty":1.059917,"marketCap":2017728299},{"date":"2025-01-31","current":2.921251,"twenty":-7.590762,"median":-5.428176,"eighty":1.069791,"marketCap":1969822935},{"date":"2025-02-07","current":2.911102,"twenty":-7.528899,"median":-5.414017,"eighty":1.083331,"marketCap":1962979311},{"date":"2025-02-14","current":2.818814,"twenty":-7.457827,"median":-5.394937,"eighty":1.093966,"marketCap":1899105493},{"date":"2025-02-21","current":2.87023,"twenty":-7.424613,"median":-5.383964,"eighty":1.107405,"marketCap":1933745636},{"date":"2025-02-28","current":2.920406,"twenty":-7.386592,"median":-5.373472,"eighty":1.119273,"marketCap":1967550374},{"date":"2025-03-07","current":2.88979,"twenty":-7.313942,"median":-5.350195,"eighty":1.145178,"marketCap":1946923754},{"date":"2025-03-14","current":2.642312,"twenty":-7.301796,"median":-5.303466,"eighty":1.162742,"marketCap":1780191908},{"date":"2025-03-21","current":2.781784,"twenty":-7.301796,"median":-5.281679,"eighty":1.188308,"marketCap":1874157622},{"date":"2025-03-28","current":2.622752,"twenty":-7.301796,"median":-5.241404,"eighty":1.240864,"marketCap":1767013790},{"date":"2025-04-04","current":2.356565,"twenty":-7.301796,"median":-5.21158,"eighty":1.319053,"marketCap":1587676787},{"date":"2025-04-11","current":2.15246,"twenty":-7.300847,"median":-5.158419,"eighty":1.451223,"marketCap":1450165986},{"date":"2025-04-17","current":2.30809,"twenty":-7.300847,"median":-5.134478,"eighty":1.549215,"marketCap":1555017972},{"date":"2025-04-25","current":2.488383,"twenty":-7.257818,"median":-5.065031,"eighty":1.606516,"marketCap":1676485846},{"date":"2025-05-02","current":2.690596,"twenty":-7.245969,"median":-5.039184,"eighty":1.628296,"marketCap":1791896257},{"date":"2025-05-09","current":2.438407,"twenty":-7.245969,"median":-4.936015,"eighty":1.631408,"marketCap":1623942179},{"date":"2025-05-16","current":2.457538,"twenty":-7.211085,"median":-4.825644,"eighty":1.643855,"marketCap":1636683523},{"date":"2025-05-23","current":2.573197,"twenty":-7.184515,"median":-4.783348,"eighty":1.672377,"marketCap":1713710738},{"date":"2025-05-30","current":2.768861,"twenty":-7.176606,"median":-4.76851,"eighty":1.683824,"marketCap":1844019936},{"date":"2025-06-06","current":2.920174,"twenty":-7.162855,"median":-4.728102,"eighty":1.695343,"marketCap":1944792382},{"date":"2025-06-13","current":3.000179,"twenty":-7.150034,"median":-4.696523,"eighty":1.708011,"marketCap":1998074365},{"date":"2025-06-20","current":3.087141,"twenty":-7.133475,"median":-4.666837,"eighty":1.715198,"marketCap":2055989564},{"date":"2025-06-27","current":2.926262,"twenty":-7.123743,"median":-4.647685,"eighty":1.722754,"marketCap":1948846446},{"date":"2025-07-03","current":3.136709,"twenty":-7.113765,"median":-4.596611,"eighty":1.740756,"marketCap":2089001227},{"date":"2025-07-11","current":3.437597,"twenty":-7.095212,"median":-4.569492,"eighty":1.76113,"marketCap":2289387816},{"date":"2025-07-18","current":3.508905,"twenty":-7.074749,"median":-4.511196,"eighty":1.782837,"marketCap":2336878279},{"date":"2025-07-25","current":3.448032,"twenty":-7.052346,"median":-4.477892,"eighty":1.821804,"marketCap":2296337640},{"date":"2025-08-01","current":3.326558,"twenty":-7.028644,"median":-4.449129,"eighty":2.145603,"marketCap":2162538499},{"date":"2025-08-08","current":3.312257,"twenty":-7.010572,"median":-4.423394,"eighty":2.206509,"marketCap":2153242257},{"date":"2025-08-15","current":3.278295,"twenty":-7.001731,"median":-4.397105,"eighty":2.314894,"marketCap":2131163680},{"date":"2025-08-22","current":3.414146,"twenty":-6.975637,"median":-4.376466,"eighty":2.354014,"marketCap":2219477987},{"date":"2025-08-29","current":3.412358,"twenty":-6.950795,"median":-4.359814,"eighty":2.377968,"marketCap":2218315957},{"date":"2025-09-05","current":3.229138,"twenty":-6.926725,"median":-4.351488,"eighty":2.420223,"marketCap":2099207845},{"date":"2025-09-12","current":3.262207,"twenty":-6.919274,"median":-4.329537,"eighty":2.432641,"marketCap":2120705407},{"date":"2025-09-19","current":3.391802,"twenty":-6.902988,"median":-4.317427,"eighty":2.447871,"marketCap":2204952608},{"date":"2025-09-26","current":3.272038,"twenty":-6.886228,"median":-4.295382,"eighty":2.457661,"marketCap":2127096573},{"date":"2025-10-03","current":3.568765,"twenty":-6.874742,"median":-4.270498,"eighty":2.461547,"marketCap":2319993613},{"date":"2025-10-10","current":3.792204,"twenty":-6.860127,"median":-4.250818,"eighty":2.471505,"marketCap":2465247408},{"date":"2025-10-17","current":3.710872,"twenty":-6.839615,"median":-4.233151,"eighty":2.481375,"marketCap":2412375027},{"date":"2025-10-24","current":3.761816,"twenty":-6.829929,"median":-4.194807,"eighty":2.491957,"marketCap":2445492892},{"date":"2025-10-31","current":-6.252286,"twenty":-6.808731,"median":-4.190183,"eighty":2.495828,"marketCap":2508823547},{"date":"2025-11-07","current":-5.858048,"twenty":-6.777293,"median":-4.190183,"eighty":2.495828,"marketCap":2350629761},{"date":"2025-11-14","current":-6.182123,"twenty":-6.757802,"median":-4.190183,"eighty":2.495828,"marketCap":2480669562},{"date":"2025-11-21","current":-3.570634,"twenty":-6.724907,"median":-4.170921,"eighty":2.495828,"marketCap":1432770360},{"date":"2025-11-28","current":-4.243488,"twenty":-6.652881,"median":-4.162031,"eighty":2.495828,"marketCap":1702763310},{"date":"2025-12-05","current":-3.98481,"twenty":-6.642828,"median":-4.130916,"eighty":2.495828,"marketCap":1598964725},{"date":"2025-12-12","current":-3.990623,"twenty":-6.626159,"median":-4.122025,"eighty":2.495828,"marketCap":1601297277},{"date":"2025-12-19","current":-3.593886,"twenty":-6.59251,"median":-4.091867,"eighty":2.495828,"marketCap":1442100570},{"date":"2025-12-26","current":-4.239128,"twenty":-6.579102,"median":-4.069098,"eighty":2.495828,"marketCap":1701013896},{"date":"2026-01-02","current":-3.955745,"twenty":-6.571454,"median":-4.05535,"eighty":2.495828,"marketCap":1587301962},{"date":"2026-01-09","current":-4.09235,"twenty":-6.553799,"median":-4.034342,"eighty":2.495828,"marketCap":1642116945},{"date":"2026-01-16","current":-4.040033,"twenty":-6.51253,"median":-4.034342,"eighty":2.495828,"marketCap":1621123973},{"date":"2026-01-23","current":-4.165013,"twenty":-6.490381,"median":-4.013863,"eighty":2.495828,"marketCap":1671273851},{"date":"2026-01-30","current":-4.012422,"twenty":-6.470512,"median":-4.012422,"eighty":2.495828,"marketCap":1610044349},{"date":"2026-02-06","current":-3.861284,"twenty":-6.438402,"median":-3.996083,"eighty":2.495828,"marketCap":1549397984},{"date":"2026-02-13","current":-3.965465,"twenty":-6.374407,"median":-3.991954,"eighty":2.495828,"marketCap":1636868702},{"date":"2026-02-20","current":-4.056786,"twenty":-6.365657,"median":-3.98917,"eighty":2.495828,"marketCap":1674564275},{"date":"2026-02-27","current":-4.255509,"twenty":-6.317735,"median":-3.98917,"eighty":2.495828,"marketCap":1756593316},{"date":"2026-03-06","current":-3.929036,"twenty":-6.250047,"median":-3.987716,"eighty":2.495828,"marketCap":1621831320},{"date":"2026-03-13","current":-3.916261,"twenty":-6.164969,"median":-3.984394,"eighty":2.495828,"marketCap":1616558025},{"date":"2026-03-20","current":-3.963103,"twenty":-6.114945,"median":-3.975302,"eighty":2.495828,"marketCap":1635893442},{"date":"2026-03-27","current":-4.251251,"twenty":-6.075039,"median":-3.971731,"eighty":2.495828,"marketCap":1754835551},{"date":"2026-04-02","current":-4.853097,"twenty":-6.031904,"median":-3.971731,"eighty":2.495828,"marketCap":2003266360},{"date":"2026-04-10","current":-4.672827,"twenty":-5.979231,"median":-3.971731,"eighty":2.495828,"marketCap":1928854302},{"date":"2026-04-17","current":-4.956717,"twenty":-5.930092,"median":-3.971731,"eighty":2.495828,"marketCap":2046038646},{"date":"2026-04-24","current":-3.653663,"twenty":-5.888865,"median":-3.964464,"eighty":2.495828,"marketCap":1508162507},{"date":"2026-05-01","current":-3.940353,"twenty":-5.873087,"median":-3.955745,"eighty":2.495828,"marketCap":1665205052},{"date":"2026-05-08","current":-3.874211,"twenty":-5.873087,"median":-3.962869,"eighty":2.495828,"marketCap":1637253395},{"date":"2026-05-15","current":-4.043084,"twenty":-5.873087,"median":-3.964464,"eighty":2.495828,"marketCap":1708619326},{"date":"2026-05-22","current":-4.051527,"twenty":-5.873087,"median":-3.969906,"eighty":2.492744,"marketCap":1712187623},{"date":"2026-05-29","current":-4.280912,"twenty":-5.874105,"median":-3.978284,"eighty":2.490424,"marketCap":1809126345},{"date":"2026-06-05","current":-4.051527,"twenty":-5.873087,"median":-3.984394,"eighty":2.483226,"marketCap":1712187623},{"date":"2026-06-12","current":-4.041676,"twenty":-5.873087,"median":-3.985899,"eighty":2.470183,"marketCap":1708024610},{"date":"2026-06-18","current":-4.655246,"twenty":-5.873087,"median":-3.990072,"eighty":2.456401,"marketCap":1967320825},{"date":"2026-06-26","current":-5.094314,"twenty":-5.874105,"median":-3.993756,"eighty":2.424453,"marketCap":2152872245},{"date":"2026-07-02","current":-5.218153,"twenty":-5.874105,"median":-3.999993,"eighty":2.379054,"marketCap":2205207261},{"date":"2026-07-10","current":-6.021704,"twenty":-5.888865,"median":-4.013142,"eighty":2.336325,"marketCap":2544790149},{"date":"2026-07-17","current":-5.448945,"twenty":-5.888865,"median":-4.027279,"eighty":2.246281,"marketCap":2302740700},{"date":"2026-07-24","current":-5.105572,"twenty":-5.888865,"median":-4.040855,"eighty":2.190786,"marketCap":2157629974},{"date":"2026-07-31","current":-4.735622,"twenty":-5.888865,"median":-4.048713,"eighty":2.139193,"marketCap":1947695194},{"date":"2026-08-07","current":-4.637831,"twenty":-5.888865,"median":-4.05535,"eighty":2.139193,"marketCap":1907475129},{"date":"2026-08-14","current":-4.858473,"twenty":-5.888865,"median":-4.065722,"eighty":2.139193,"marketCap":1998221990},{"date":"2026-08-21","current":-4.881699,"twenty":-5.888865,"median":-4.09235,"eighty":2.139193,"marketCap":2007774291},{"date":"2026-08-28","current":-4.976052,"twenty":-5.888865,"median":-4.105491,"eighty":2.139193,"marketCap":2046580514},{"date":"2026-09-04","current":-4.809119,"twenty":-5.888865,"median":-4.122025,"eighty":2.139193,"marketCap":1977923350},{"date":"2026-09-11","current":-4.88315,"twenty":-5.888865,"median":-4.130861,"eighty":2.139193,"marketCap":2008371310},{"date":"2026-09-18","current":-4.878795,"twenty":-5.888865,"median":-4.144851,"eighty":2.139193,"marketCap":2006580254},{"date":"2026-09-25","current":-4.775733,"twenty":-5.888865,"median":-4.151889,"eighty":2.139193,"marketCap":1964191917},{"date":"2026-10-02","current":-4.714766,"twenty":-5.888865,"median":-4.167558,"eighty":2.139193,"marketCap":1939117127}],"updateTime":1791068747541},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"AGIO\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2639676217","title":"Agios Pharmaceuticals price target lowered to $40 from $41 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2639676217","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639676217?lang=en_us&edition=fundamental","pubTime":"2026-05-29 23:28","pubTimestamp":1780068523,"startTime":"0","endTime":"0","summary":"BofA lowered the firm’s price target on Agios Pharmaceuticals (AGIO) to $40 from $41 and keeps a Buy rating on the shares after the company announc...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-40-from-41-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-pharmaceuticals-price-target-lowered-to-40-from-41-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639620012","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, Replimune","url":"https://stock-news.laohu8.com/highlight/detail?id=2639620012","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639620012?lang=en_us&edition=fundamental","pubTime":"2026-05-29 21:21","pubTimestamp":1780060878,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tempus AI, SOLV Energy, ReplimuneWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslett","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL6N4260OV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4182","LU0211326839.USD","LU1046421795.USD","LU1116320901.HKD","REPL","LU0079474960.USD","COSW","LU0496365809.HKD","LU1116320737.USD","LU1496350502.SGD","BK4602","LU0267386448.USD","TEM","PL","LU2065171311.SGD","PLU","UFO","BK4585","LU0471298694.HKD","LU0048573561.USD","LU0823434583.USD","LU1496350171.SGD","LU0943347566.SGD","LU1066053197.SGD","LU2360106947.USD","LU0251131958.USD","LU0823434740.USD","AEO","BK4129","LU1267930227.SGD","IE00B5TLWC47.USD","LU1861558580.USD","BK4170","LU0689472784.USD","LU0128525689.USD","TEMT","LU0251142724.SGD","BK4187","BK4581","LU2065169927.USD","AGIO","LU1551013342.USD","FLYT","LU0234572021.USD","BK4588","LU1066051498.USD","LUNL","BK4561","BK4613","BK4121","LU2125154935.USD","LU0742534661.SGD","DELL","DLLL","LU0310800965.SGD","KRMN","LU0385154629.USD","LU1066051225.USD","LU0314106906.USD","LU0238689110.USD","IFF","LU1923622614.USD","LU2360032135.SGD","FPS","LU2168564065.EUR","BK4109","LU2237438978.USD","BK4596","LU2168564149.EUR","BK4504","LU2210150020.SGD","LU2097829019.USD","LU0265550359.USD","BK4615","LU2125154778.USD","LU0820561909.HKD","LU0820561818.USD","LU1571399168.USD","RKLB","RKLX","COTG","LU0417517546.SGD","BK4139","IE0008368304.USD","BK4535","BK4123","IE00BKVL7J92.USD","MWH","LU2433249047.HKD","LU1235294995.USD","LU2065170008.USD","IE00BZ1G4Q59.USD","FLY","LU0052756011.USD","LU2381873111.SGD","LU2168564222.USD","LU0234570918.USD","BK4543","LU1506573853.SGD","LU2065171402.SGD","COST","LU0211326755.USD","LU1551013425.SGD","LU2168564495.EUR","LU2125909593.SGD","LU0256863811.USD","LU1066051811.HKD","LU2210149790.SGD","HK0000819398.USD","LU0265550946.USD","BK4533","LU1035775433.USD","LU2125909247.SGD","BK4550","LU1069344957.HKD","LU2095319765.USD","LU1861559042.SGD","LU0985320562.USD","RKLZ","LU0976567544.SGD","LUNR","BK4564","GAP","BK4611","BK4094","LU1823568750.SGD","LU2168563687.JPY","LU0471298777.SGD","BK4155","BK4515","LU1323610961.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639762712","title":"BRIEF-Agios Provides Update On Phase 2B Trial Of Tebapivat In Lower-Risk Myelodysplastic Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2639762712","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639762712?lang=en_us&edition=fundamental","pubTime":"2026-05-29 20:32","pubTimestamp":1780057976,"startTime":"0","endTime":"0","summary":"BRIEF-Agios Provides Update On Phase 2B Trial Of Tebapivat In Lower-Risk Myelodysplastic SyndromesMay 29 (Reuters) - Agios Pharmaceuticals Inc AGIO.O:AGIOS PROVIDES UPDATE ON PHASE 2B TRIAL OF TEBAPIV","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7F3TVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639362408","title":"BUZZ-U.S. STOCKS ON THE MOVE-Costco, Firefly Aerospace, Agios","url":"https://stock-news.laohu8.com/highlight/detail?id=2639362408","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639362408?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:39","pubTimestamp":1780054763,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Costco, Firefly Aerospace, AgiosWorkspace search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newslette","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL6N4260PK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0234570918.USD","LU0471298777.SGD","LU2125154935.USD","LU2168564065.EUR","LU0211326755.USD","LU2168563687.JPY","LU1066051225.USD","LU2168564495.EUR","LU1823568750.SGD","KRMN","LU0238689110.USD","IE00BKVL7J92.USD","GAP","COTG","LU1116320737.USD","IE0008368304.USD","LU2360032135.SGD","LU2360106947.USD","LU2065170008.USD","LU1571399168.USD","LU2095319765.USD","AGIO","COST","FLY","LU2433249047.HKD","LU1323610961.USD","BK4123","LU0256863811.USD","LU1116320901.HKD","LU2125909593.SGD","LU1066051498.USD","LUNL","LU0976567544.SGD","PL","BK4094","RKLZ","LU2125154778.USD","BK4564","LU0820561909.HKD","LU2125909247.SGD","LU1066051811.HKD","LU2168564222.USD","BK4550","COSW","PLU","LU2210150020.SGD","FLYT","LU0943347566.SGD","BK4535","LU0265550359.USD","LU0310800965.SGD","LU1496350171.SGD","IE00B5TLWC47.USD","BK4139","BK4187","BK4504","BK4585","IE00BZ1G4Q59.USD","LU1069344957.HKD","LU0128525689.USD","AEO","LU0079474960.USD","BK4588","BK4596","BK4533","BK4602","LU0417517546.SGD","LU1551013342.USD","LU0211326839.USD","LU0267386448.USD","LU1235294995.USD","LU1267930227.SGD","RKLX","BK4170","LU0471298694.HKD","UFO","LU2065171402.SGD","LU1035775433.USD","LU0234572021.USD","LU0823434583.USD","LU0820561818.USD","LU0265550946.USD","LU1066053197.SGD","LU1551013425.SGD","LU0052756011.USD","BK4515","LU2210149790.SGD","LU2065169927.USD","HK0000819398.USD","RKLB","LU2168564149.EUR","LUNR","BK4581","LU1046421795.USD","BK4615","LU0385154629.USD","DELL","LU2381873111.SGD","LU0496365809.HKD","DLLL","LU2065171311.SGD","LU0689472784.USD","LU1923622614.USD","LU2097829019.USD","LU2237438978.USD","BK4543","BK4155","LU0823434740.USD","LU1496350502.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639242486","title":"Agios Pharma Won't Advance Tebapivat for Lower-Risk Myelodysplastic Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2639242486","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639242486?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:30","pubTimestamp":1780054200,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals said it won't advance its tebapivat, an oral pyruvate kinase activator, in lower-risk myelodysplastic syndromes, after a Phase 2b trial didn't meet the company's predefined threshold to support further development in this indication.The commercial-stage biopharmaceutical company said the 24-week dose-finding trial evaluated once-daily tebapivat in 65 patients with LR-MDS and anemia.The primary endpoint was transfusion independence, defined as eight consecutive weeks without a transfusion during the 24-week treatment period. Agios said tebapivat demonstrated evidence of biological activity, but that it didn't see clinical benefit in a sufficient proportion of patients or subgroup of patients to meet the company's predefined threshold for advancement.Tebapivat was well tolerated across all dose levels, with no new safety signals identified.Agios said tebapivat is also being evaluated in a Phase 2 trial for the treatment of sickle cell disease, with top-line data ant","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639162624","title":"Agios Halts Development of Tebapivat in Lower-Risk MDS After Mid-Stage Trial Miss; Shares Drop Premarket","url":"https://stock-news.laohu8.com/highlight/detail?id=2639162624","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639162624?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:27","pubTimestamp":1780054063,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals  is set to discontinue development of tebapivat for lower-risk myelodysplastic syndromes after a phase 2b study failed to meet the company's threshold for further advancement, the company said on Friday.The open-label trial evaluated three dose levels of the oral pyruvate kinase activator in 65 patients with lower-risk MDS and anemia, it said. The primary endpoint measured transfusion independence over eight consecutive weeks during a 24-week treatment period, it added.Agios said tebapivat showed biological activity and was well tolerated, with no new safety concerns identified. However, the company said clinical benefit was not observed in enough patients to justify continued development in the indication, it added.Shares of Agios more down more than 6% in recent premarket trading.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO","SSI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639624969","title":"Agios will not advance tebapivat in lower-risk myelodysplastic syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2639624969","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639624969?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:08","pubTimestamp":1780052897,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals (AGIO) announced that it will not advance tebapivat, a next-generation oral pyruvate kinase activator, in lower-risk myelodys...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agios-will-not-advance-tebapivat-in-lower-risk-myelodysplastic-syndromes-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agios-will-not-advance-tebapivat-in-lower-risk-myelodysplastic-syndromes-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639662101","title":"Agios Pharmaceuticals Shares Fall 19% Premarket After Co to Stop Development of Its Blood Disorder Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2639662101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639662101?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:07","pubTimestamp":1780052835,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N426105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621098","title":"Agios scraps blood disorder drug program after study miss","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621098","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621098?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:05","pubTimestamp":1780052715,"startTime":"0","endTime":"0","summary":"Agios scraps blood disorder drug program after study missMay 29 (Reuters) - Agios Pharmaceuticals AGIO.O said on Friday it will stop developing its experimental drug for a form of blood cancer after a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nL4N4260ZU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621736","title":"Agios Pharmaceuticals - Tebapivat Phase 2 Trial in Sickle Cell Disease Topline Data Expected Second Half 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621736","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621736?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:00","pubTimestamp":1780052400,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7F3TVS:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639621734","title":"Agios Pharmaceuticals - Phase 2B Trial Results for Tebapivat in Lr-Mds Did Not Meet Predefined Threshold","url":"https://stock-news.laohu8.com/highlight/detail?id=2639621734","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639621734?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:00","pubTimestamp":1780052400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7F3TVS:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639217316","title":"Agios Pharmaceuticals - Tebapivat Well Tolerated With No New Safety Signals Identified","url":"https://stock-news.laohu8.com/highlight/detail?id=2639217316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639217316?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:00","pubTimestamp":1780052400,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7F3TVS:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639212906","title":"Agios Pharmaceuticals - Will Not Advance Tebapivat in Lower-Risk Myelodysplastic Syndromes","url":"https://stock-news.laohu8.com/highlight/detail?id=2639212906","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639212906?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:00","pubTimestamp":1780052400,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nTUA7F3TVS:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638589460","title":"Analysts Offer Insights on Healthcare Companies: Clinuvel Pharmaceuticals (OtherCLVLF) and Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2638589460","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638589460?lang=en_us&edition=fundamental","pubTime":"2026-05-25 09:50","pubTimestamp":1779673827,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Clinuvel Pharmaceuticals (CLVLF) and Agios Pharma (A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-clinuvel-pharmaceuticals-otherclvlf-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-clinuvel-pharmaceuticals-otherclvlf-and-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CLVLF","BK4581","BK4588","XLV","LU0128526141.USD","HCSG","BK4137","BK4585","LU0029874061.USD","XBI","LABU","AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638301307","title":"Will EU Thalassemia Approval for PYRUKYND Redefine Agios Pharmaceuticals' (AGIO) Mitapivat-Centric Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2638301307","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638301307?lang=en_us&edition=fundamental","pubTime":"2026-05-25 00:20","pubTimestamp":1779639610,"startTime":"0","endTime":"0","summary":"Earlier in May 2026, the European Commission granted marketing authorization for Agios Pharmaceuticals’ PYRUKYND (mitapivat) to treat anemia in adults with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia, making it the only approved medicine across all EU member states for this broad thalassemia population.\nThis decision not only broadens PYRUKYND’s labeled use beyond pyruvate kinase deficiency but also deepens Agios’ footprint in rare hematologic diseases...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/will-eu-thalassemia-approval-for-pyrukynd-redefine-agios-pha","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-agio/agios-pharmaceuticals/news/will-eu-thalassemia-approval-for-pyrukynd-redefine-agios-pha","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["AGIO","BK4139","AIPO","BK4156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637345356","title":"Analysts Are Bullish on These Healthcare Stocks: Bicara Therapeutics Inc. (BCAX), Agios Pharma (AGIO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2637345356","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637345356?lang=en_us&edition=fundamental","pubTime":"2026-05-23 00:01","pubTimestamp":1779465665,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bicara Therapeutics Inc. (BCAX), Agios Pharma (AGIO)...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bicara-therapeutics-inc-bcax-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-bicara-therapeutics-inc-bcax-agios-pharma-agio-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BCAX","BK4139","AGIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637834838","title":"BRIEF-Avanzanite Bioscience’S Partner Agios Announces Pyrukynd® (Mitapivat) Approval In EU","url":"https://stock-news.laohu8.com/highlight/detail?id=2637834838","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637834838?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:38","pubTimestamp":1779460718,"startTime":"0","endTime":"0","summary":"BRIEF-Avanzanite Bioscience’S Partner Agios Announces Pyrukynd  Approval In EUMay 22  - Avanzanite Bioscience B.V:AVANZANITE BIOSCIENCE’S PARTNER AGIOS ANNOUNCES PYRUKYND  APPROVAL IN THE EUROPEAN UNION FOR ADULTS WITH THALASSAEMIASource text: ID:nBws6nRza ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nTUA2RHSSZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637310541","title":"Agios Gets EU Approval for Pyrukynd in Thalassemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637310541","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637310541?lang=en_us&edition=fundamental","pubTime":"2026-05-22 22:12","pubTimestamp":1779459164,"startTime":"0","endTime":"0","summary":"Agios Pharmaceuticals  said Friday the European Commission granted marketing authorization for Pyrukynd to treat adults with anemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassemia.The oral therapy received orphan medicinal product designation in the European Union.The approval was based on results from the two phase 3 clinical trials evaluating the medicine in adults with thalassemia, Agios said.The company added that its partner, Avanzanite Bioscience, will continue to commercialize and distribute Pyrukynd across Europe.Price: 28.58, Change: -0.21, Percent Change: -0.73","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["AGIO","BK4139","BK4156"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637604312","title":"Agios says EU approves PYRUKYND for adults with alpha- or beta-thalassemia anemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637604312","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637604312?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:15","pubTimestamp":1779455741,"startTime":"0","endTime":"0","summary":"Agios won European Commission marketing authorization for PYRUKYND  to treat anemia in adults with transfusion-dependent or non-transfusion-dependent alpha- or beta-thalassemia across the EU.The decision expands mitapivat’s thalassemia label to a fourth major market, following prior clearances in the U.S., Saudi Arabia, and the United Arab Emirates.Avanzanite Bioscience will continue to distribute and commercialize PYRUKYND in Europe under an exclusive agreement covering the European Economic Area, the UK, and Switzerland.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLbydnCn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","NDAQ","LU2210150020.SGD","IE00B64PRP62.GBP","LU2210149790.SGD","IE00BGHQF748.EUR","SG9999014013.SGD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4588","SG9999014005.SGD","IE00BN0W2W23.USD","AGIO","SG9999014021.USD","BK4585","LU2095319765.USD","SG9999014039.USD","BK4139","IE00B3QW5Z07.USD","LU0314104364.USD","IE00BKPKM429.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637731267","title":"Agios’ Pyrukynd® (Mitapivat) Approved in the European Union for Adults With Thalassemia","url":"https://stock-news.laohu8.com/highlight/detail?id=2637731267","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637731267?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:15","pubTimestamp":1779455726,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z0N4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["AGIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":5,"totalSize":151,"code":"91000000","status":"200"}]}}